Sara Motka: We Create Greater Synergies Between Haemophilia and Haemoglobinopathies
Sara Motka, Head of Programmes at the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, reposted from Novo Nordisk Haemophilia and Haemoglobinopathies Foundation on LinkedIn:
”Thrilled to announce the expansion of NNHF! We will amplify our efforts in data-driven advocacy, forge stronger partnerships, and create greater synergies between haemophilia and haemoglobinopathies. Our mission goes beyond connecting and building opportunities for the global bleeding disorders community; we will aim to make a meaningful contribution to sickle cell disease and thalassaemia too. We will continue to connect, enable, and accelerate. Impacting care – Together!”
Qutoing Novo Nordisk Haemophilia and Haemoglobinopathies Foundation‘s post:
”We are now the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation!
Proudly, we are unveiling our Foundation’s new chapter:
We are expanding our support beyond people with haemophilia to people with sickle cell disease and thalassaemia as well.
Building on two decades of work in haemophilia, and enabled by a renewed partnership with the Novo Nordisk Foundation and the continued funding from our founder Novo Nordisk, we are expanding our scope to include haemoglobinopathies. We will apply our proven, partnership-led model to develop tailored programmes that benefit people with haemophilia and haemoglobinopathies, their healthcare professionals, and families – always adapted to local needs.
Let us tell you more here.
Ludovic Helfgott, Mads Krogsgaard Thomsen, Maziar Mike Doustdar, Amy Shapiro, Stephanie Seremetis, Johnny Mahlangu, Ognenka Kozar, Denise B., Amos Gitonga M, Llyord Mwaniki, Célia Rohrer, Gatoto Carole, Sara Motka, Xio Fong Vilaysane, Elisa Eleftheriou, Natasha Honan.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 16:53Flora Peyvandi: A New Approach to Coagulation with Bispecific Antibodies
-
Sep 10, 2026, 16:52Francisco Chacón-Lozsán: Perhaps We Are Treating ‘Sepsis’ When We Should Be Treating an Immune Phenotype
-
Sep 10, 2026, 16:46Aswin K Mohan: HLA Beyond Histocompatibility – Redefining Immune Recognition in Modern Medicine
-
Sep 10, 2026, 16:40Satyam Arora: Pediatric Apheresis – When Every Millilitre Matters
-
Sep 10, 2026, 16:39Marco Moscarelli: When CT Reveals Thrombosis After TAVI
-
Sep 10, 2026, 16:23Antonio Paul: When a Low Platelet Count Does Not Mean Weak Clotting
-
Sep 10, 2026, 16:12Balancing Thrombosis and Bleeding in Antiphospholipid Syndrome
-
Sep 10, 2026, 16:07Miguel Teran: Why ROTEM Will Redefine Major Bleeding Management
-
Sep 10, 2026, 16:04Isaac Okello: Where Skyline Meets Savannah – Quiet Moments at GASCDO in Nairobi